Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Mandar Deepak Muzumdar

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0001-7424-7223; OpenAlex author ID A5022988942; NIH RePORTER profile ID 11474116. Sources: OpenAlex.

Their work

Papers
11 (first author 3, last author 5)
Trials
0
Grants
5
Labs led
2
Collaborators
43
Papers, trials and grants by year

2017: 1 paper · 2018: 3 papers · 2019: 1 paper · 2020: 1 paper, 1 grant · 2021: none · 2022: 1 grant · 2023: 1 paper · 2024: 2 papers · 2025: none · 2026: 2 papers, 3 grants

Papers 11

  1. Beta cell-derived cholecystokinin drives obesity-associated pancreatic adenocarcinoma development. Last author DOI 10.1038/s41467-026-69821-2↗
  2. Baseline cellular state shapes the molecular impact of mutant Kirsten rat sarcoma viral oncogene homologue (KRAS) alleles in reconstituted pancreatic cancer ce… Last author DOI 10.1093/molecular-omics/aaiag022↗
  3. Perioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer: A Nonrandomized Controlled Trial. Co-author DOI 10.1001/jamaoncol.2024.1575↗
  4. Keep It Moving: Physical Activity in the Prevention of Obesity-Driven Pancreatic Cancer. First author DOI 10.1158/0008-5472.can-24-1474↗
  5. Decoding the obesity-cancer connection: lessons from preclinical models of pancreatic adenocarcinoma. Last author DOI 10.26508/lsa.202302228↗
  6. Endocrine-Exocrine Signaling Drives Obesity-Associated Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1016/j.cell.2020.03.062↗
  7. Endocrine-exocrine signaling drives obesity-associated pancreatic ductal adenocarcinoma Last author DOI 10.1101/663583↗
  8. Differences in Nanoparticle Uptake in Transplanted and Autochthonous Models of Pancreatic Cancer. First author DOI 10.1021/acs.nanolett.7b04043↗
  9. Adaptive and Reversible Resistance to Kras Inhibition in Pancreatic Cancer Cells. First author DOI 10.1158/0008-5472.can-17-2129↗
  10. iRGD-guided Tumor-penetrating Nanocomplexes for Therapeutic siRNA Delivery to Pancreatic Cancer. Co-author DOI 10.1158/1535-7163.mct-17-1090↗
  11. Survival of pancreatic cancer cells lacking KRAS function. Co-author DOI 10.1038/s41467-017-00942-5↗

Grants 5

  1. Dietary fatty acids drive pancreatic cancer development R01CA276108↗
  2. 3D genome reorganization drives cancer development R01CA292936↗
  3. Targeting pancreatic endocrine-exocrine signaling in cancer development with incretin mimetics R01CA296916↗
  4. Innovation & Collaboration grant: Mandar Muzumdar AWARD lustgarten:2022-mandar-muzumdar-innovation-collaboration-grant-mandar-mu
  5. Elucidating KRAS-specific vulnerabilities in pancreatic cancer K08CA208016↗

Closest collaborators

The 25 strongest of 43 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Siyuan Wang · 1 shared grant, 2026 · strength 1.26
  2. Akin Sogunro · 2 shared papers, 2024–2026 · strength 0.70
  3. Cathy C. Garcia · 4 shared papers, 2019–2026 · strength 0.62
  4. Christian Felipe Ruiz · 2 shared papers, 2023–2026 · strength 0.48
  5. Tyler Jacks · 6 shared papers, 2017–2020 · strength 0.43
  6. Yanixa Quiñones-Avilés · 1 shared paper, 2026 · strength 0.33
  7. Brian Matthew Wolpin · 3 shared papers, 2018–2020 · strength 0.21
  8. Charles S. Fuchs · 3 shared papers, 2018–2020 · strength 0.21
  9. Katherine Minjee Chung · 3 shared papers, 2017–2020 · strength 0.21
  10. Ana Babić · 2 shared papers, 2019–2020 · strength 0.14
  11. Albert C. Koong · 2 shared papers, 2019–2020 · strength 0.14
  12. Melena D. Bellin · 2 shared papers, 2019–2020 · strength 0.14
  13. Richard Francis Dunne · 2 shared papers, 2019–2020 · strength 0.14
  14. Andressa Dias Costa · 2 shared papers, 2019–2020 · strength 0.14
  15. Sara A. Väyrynen · 2 shared papers, 2019–2020 · strength 0.14
  16. Daniel Tandel Chang · 2 shared papers, 2019–2020 · strength 0.14
  17. Aram F. Hezel · 2 shared papers, 2019–2020 · strength 0.14
  18. Jonathan Andrew Nowak · 2 shared papers, 2019–2020 · strength 0.14
  19. Charles H. Cha · 1 shared paper, 2024 · strength 0.14
  20. Stacey Stein · 1 shared paper, 2024 · strength 0.14
  21. John W. Kunstman · 1 shared paper, 2024 · strength 0.14
  22. Ronald R. Salem · 1 shared paper, 2024 · strength 0.14
  23. Michael Cecchini · 1 shared paper, 2024 · strength 0.14
  24. Guoping Cai · 1 shared paper, 2024 · strength 0.14
  25. Luisa F. Escobar‐Hoyos · 1 shared paper, 2024 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.